Alkuri Global Acquisition Corp. (KURI) Shareholders Approve Babylon Health Deal
by Marlena Haddad on 2021-10-20 at 5:04pm

Alkuri Global Acquisition Corp. (NASDAQ:KURI) announced in an 8-K filing today that it secured shareholder approval of its combination with digital healthcare company Babylon in a special meeting held this morning.

Although KURI did not disclose its redemption numbers, it traded slightly above $10 throughout its redemption deadline October 18 and reached $10.02 today.  The business combination received 30,577,965 votes in favor of the deal and 1,242,574 against it.

The deal is expected to close tomorrow, October 21, and the combined company’s shares and warrants are expected to begin trading on the New York Stock Exchange under the symbols “BBLN” and “BBLN.W,” respectively, Friday, October 22.

Alkuri Global and Babylon initially announced the $3.6 billion deal on June 3. London-based Babylon provides digital self-help care tools and telemedicine services to patients in North America, Europe and Asia and engaged with a patient once every five seconds in 2020.

Earlier this month, Babylon secured a sustainability-linked investment of up to $200 million from Albacore Capital Group, a strategic capital investment firm.

All other proposals were approved at today’s special meeting.  For a full list of tallies and proposals, you may click here.


ADVISORS

  • Ardea Partners LP is serving as financial advisor to Babylon.
  • Citi is serving as financial and capital markets advisor to Babylon.
  • Wilson Sonsini Goodrich & Rosati, P.C., Allen & Overy LLP and Walkers (Jersey) LLP are serving as legal counsel to Babylon.
  • Jefferies is serving as exclusive financial advisor to Alkuri Global.
  • Winston & Strawn LLP is serving as legal counsel to Alkuri Global.
  • Jefferies, Citi and Pareto Securities AB served as placement agents on the PIPE.
Recent Posts
by Kristi Marvin on 2024-10-26 at 10:00am

Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced.  That brings October’s tally to seven IPOs with one more...

by Nicholas Alan Clayton on 2024-10-25 at 8:15am

At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...

by Nicholas Alan Clayton on 2024-10-24 at 11:54am

DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...

by Nicholas Alan Clayton on 2024-10-24 at 10:18am

Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...

by Nicholas Alan Clayton on 2024-10-24 at 8:30am

At the SPAC of Dawn As the market goes through a cooling period this week, new readouts for jobless claims and new home sales are set to hit later today. Jobless claims are of course something of a proxy indicator for SPACs as to when the Fed might continue to its rate-cutting process, while home...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved